Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.
about
Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization modelInterleukin 12 and innate molecules for enhanced mucosal immunity.Evaluation of oral, subcutaneous, and nasal administration of Salmonella enteritidis-immune lymphokines on the potentiation of a protective heterophilic inflammatory response to Salmonella enteritidis in day-old chickens.Innate endogenous adjuvants prime to desirable immune responses via mucosal routesImmunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice.Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.Microvascular effects of oral interleukin-6 on ischemia/reperfusion in the murine small intestine.Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model.Host-pathogen interactions in Campylobacter infections: the host perspective.Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.An overview of methods used to clarify pathogenesis mechanisms of Campylobacter jejuni.Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice.Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparationsAdministration of Salmonella enteritidis-immune lymphokine to day-old turkeys by subcutaneous, oral, and nasal routes: A comparison of effects on Salmonella enteritidis liver invasion, peripheral blood heterophilia and heterophil activation.Oral application of cytokines.Induction of cytokines in different organs after intranasal inoculation of Campylobacter jejuni in mice.Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.
P2860
Q30432472-6D1063F5-9BBE-4D11-92F9-1A095BD40F9AQ33878179-F66D983D-DB45-456B-AEC1-3D6EDFF38636Q33923312-2DD25888-DA73-47DD-8AE7-5639AD68E5B1Q35143128-E2121329-6097-4879-BE68-9BA91EF66787Q35440298-58DB86F4-4173-42F8-9CE7-3E7A03E6A61EQ35530786-080CCD92-3B6E-42A7-B8E1-2382F885B516Q35689435-5D84A6D2-73F3-4864-BD41-17E7257C4283Q35810057-568C9679-53FD-4C52-9AF4-28A490689AEEQ35833473-3502D34D-7838-46F6-B07C-61048731726EQ36803887-8A2AF380-AA19-4008-BC7F-AACFD076F8DAQ36872727-706718A6-6F5D-4BC0-9FEE-DFBE9DD551A4Q36994238-27E6C934-E5B9-452D-8D19-B62C9CC45896Q37727549-0800C261-92EE-44CE-985F-3F995A05F1DAQ39570241-A2A05F23-2971-4FCE-9E67-D3729B2DF232Q39780354-4E34054D-BF7A-4A8F-9C9A-7C029092AB17Q39981613-A8ECEA23-4E71-45B4-AC0B-C55193F34134Q41115941-F178D3A1-524F-4938-97B0-9F0967D58273Q42057351-F07B983E-87DC-4816-8B84-18CB6BFB55AFQ54338112-80A42779-B3D7-4C1A-AE94-12382FD63A06
P2860
Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Modulation of mucosal immunity ...... orally administered cytokines.
@ast
Modulation of mucosal immunity ...... orally administered cytokines.
@en
type
label
Modulation of mucosal immunity ...... orally administered cytokines.
@ast
Modulation of mucosal immunity ...... orally administered cytokines.
@en
prefLabel
Modulation of mucosal immunity ...... orally administered cytokines.
@ast
Modulation of mucosal immunity ...... orally administered cytokines.
@en
P2093
P2860
P356
P1476
Modulation of mucosal immunity ...... orally administered cytokines.
@en
P2093
P2860
P304
P356
10.1128/AAC.37.12.2688
P407
P577
1993-12-01T00:00:00Z